These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


340 related items for PubMed ID: 15622489

  • 21. Histologically proven hepatocellular carcinoma associated with burned-out nonalcoholic steatohepatitis.
    Kaneda K, Uenishi T, Takemura S, Yamamoto T, Sakata C, Sakae M, Urata Y, Ohata K, Tanaka S, Wakasa K, Kubo S.
    Osaka City Med J; 2013 Dec; 59(2):99-104. PubMed ID: 24575585
    [Abstract] [Full Text] [Related]

  • 22. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM, Flancbaum L, Machan JT, Charney DA, Kotler DP.
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [Abstract] [Full Text] [Related]

  • 23. [A clinicopathological study on nonalcoholic steatohepatitis].
    Lang ZW, Hu ZJ, Wang SK, Zhang LJ, Meng X, Song CZ.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Feb; 11(2):81-3. PubMed ID: 12648399
    [Abstract] [Full Text] [Related]

  • 24. Nonalcoholic steatohepatitis, animal models, and biomarkers: what is new?
    Ariz U, Mato JM, Lu SC, Martínez Chantar ML.
    Methods Mol Biol; 2010 Feb; 593():109-36. PubMed ID: 19957147
    [Abstract] [Full Text] [Related]

  • 25. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
    Helling TS, Helzberg JH, Nachnani JS, Gurram K.
    Surg Obes Relat Dis; 2008 Feb; 4(5):612-7. PubMed ID: 18226970
    [Abstract] [Full Text] [Related]

  • 26. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients.
    Shalhub S, Parsee A, Gallagher SF, Haines KL, Willkomm C, Brantley SG, Pinkas H, Saff-Koche L, Murr MM.
    Obes Surg; 2004 Jan; 14(1):54-9. PubMed ID: 14980034
    [Abstract] [Full Text] [Related]

  • 27. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.
    McCullough AJ.
    Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061
    [Abstract] [Full Text] [Related]

  • 28. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.
    Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR.
    Am J Gastroenterol; 1999 Sep; 94(9):2467-74. PubMed ID: 10484010
    [Abstract] [Full Text] [Related]

  • 29. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.
    Sanyal AJ, Banas C, Sargeant C, Luketic VA, Sterling RK, Stravitz RT, Shiffman ML, Heuman D, Coterrell A, Fisher RA, Contos MJ, Mills AS.
    Hepatology; 2006 Apr; 43(4):682-9. PubMed ID: 16502396
    [Abstract] [Full Text] [Related]

  • 30. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
    Jansen PL.
    Ned Tijdschr Geneeskd; 2005 Feb 05; 149(6):289-94. PubMed ID: 15730035
    [Abstract] [Full Text] [Related]

  • 31. Histopathology of pediatric nonalcoholic fatty liver disease.
    Schwimmer JB, Behling C, Newbury R, Deutsch R, Nievergelt C, Schork NJ, Lavine JE.
    Hepatology; 2005 Sep 05; 42(3):641-9. PubMed ID: 16116629
    [Abstract] [Full Text] [Related]

  • 32. [Nonalcoholic steatohepatitis: a clinicopathological analysis of liver biopsy in 32 cases].
    Meng JR, Zheng RD, Zhang MF, Guo YH, Lin MZ, Dai TJ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar 05; 26(3):339-41. PubMed ID: 16546742
    [Abstract] [Full Text] [Related]

  • 33. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis.
    Fujita N, Miyachi H, Tanaka H, Takeo M, Nakagawa N, Kobayashi Y, Iwasa M, Watanabe S, Takei Y.
    Cancer Epidemiol Biomarkers Prev; 2009 Feb 05; 18(2):424-32. PubMed ID: 19190144
    [Abstract] [Full Text] [Related]

  • 34. Ruptured hepatocellular carcinoma in a patient with nonalcoholic steatohepatitis.
    Smith BM, Hussain A, Jacobs M, Merrick HW.
    Surg Obes Relat Dis; 2009 Feb 05; 5(4):510-2. PubMed ID: 19342313
    [No Abstract] [Full Text] [Related]

  • 35. Liver pathology in obesity.
    Suriawinata A, Fiel MI.
    Semin Liver Dis; 2004 Nov 05; 24(4):363-70. PubMed ID: 15605304
    [Abstract] [Full Text] [Related]

  • 36. [Imaging of NASH].
    Tanimoto A, Tomita K.
    Nihon Rinsho; 2006 Jun 05; 64(6):1127-32. PubMed ID: 16768120
    [Abstract] [Full Text] [Related]

  • 37. Nonalcoholic steatohepatitis.
    Diehl AM.
    Semin Liver Dis; 1999 Jun 05; 19(2):221-9. PubMed ID: 10422202
    [Abstract] [Full Text] [Related]

  • 38. Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus.
    Orikasa H, Ohyama R, Tsuka N, Eyden BP, Yamazaki K.
    J Submicrosc Cytol Pathol; 2001 Jun 05; 33(1-2):195-200. PubMed ID: 11686402
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. NASH and HCC.
    Page JM, Harrison SA.
    Clin Liver Dis; 2009 Nov 05; 13(4):631-47. PubMed ID: 19818310
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.